healthcare
WeightWatchers Partners With Amazon for Easy Weight-Loss Drug Delivery
Novo, Lilly's Shares Drop as Trump Vows Weight-Loss Drug Price Cuts
China's Hansoh Signs up to $1.45 Billion Deal for Colorectal Cancer Drug With Roche
UK's Drug-Cost Watchdog Recommends Use of Gsk Unit's Hiv Prevention Drug
Trump, Merck KGaA Announce Deal to Cut Some Ivf Drug Prices
Date: October 16, 2025
By Patrick Wingrove (Reuters) -U.S. President Donald Trump and Germany's Merck KGaA on Thursday said they had struck a deal that would cut the cost of some drugs needed for in-vitro fertilization in...
Trump Says Price of Ozempic Will Be Lowered
Date: October 16, 2025
WASHINGTON (Reuters) -U.S. President Donald Trump said on Thursday that the price of Novo Nordisk's best-selling weight-loss drug would be lowered and that negotiations over price changes would be...
Roche to Sell Flu Pill for $50 to Cash-Paying US Patients
Date: October 16, 2025
By Patrick Wingrove (Reuters) -Roche on Thursday launched direct-to-consumer U.S. sales of its influenza antiviral pill Xofluza at a discounted cash price of $50, following similar moves by rivals as...
Germany's Merck Eyes Life Science Deals, but Muted 2026 Outlook Knocks Shares
Date: October 16, 2025
By Marleen Kaesebier (Reuters) -German pharmaceuticals and technology company Merck KGaA slightly improved its mid-term guidance for its healthcare business ahead of its capital markets day on...
Novo Nordisk Signs up to $2.1 Billion Licensing Deal With Omeros in Rare Disease Push
Date: October 15, 2025
(Reuters) -Danish drugmaker Novo Nordisk and Omeros have signed a licensing deal worth up to $2.1 billion for the U.S.-based company's experimental drug, which is being developed for rare blood and...
India's Infosys Wins $1.6 Billion Deal From UK's National Health Service
Date: October 14, 2025
BENGALURU (Reuters) -India's Infosys said on Tuesday it has won a 1.2 billion pound ($1.59 billion) deal from the UK's National Health Services Business Services Authority. The tenure of the deal will...
